Insitu Biologics, Inc
InSitu Biologics, Inc. is an emerging biotech company based in St. Paul, MN, dedicated to developing a multiphase prolonged release drug delivery platform aimed at localized treatment for pain, cancer, and infection. The company employs disruptive technology to address unmet needs in the pain management and drug delivery markets.
Currently in the investigational preclinical stage, InSitu Biologics is advancing two key products: INSB200, an extended release solution for perioperative pain management, and INSB400, an early development product designed for the local delivery of cancer drugs with a precise elution rate. These innovative solutions represent a multibillion-dollar opportunity as the company approaches Phase 1 clinical trials.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.